MAG & More
MAG & More GmbH, founded in 2002 in Munich, develops Transcranial Magnetic Stimulation (TMS) systems for treating depression and neurological conditions and for neuroscience research. A neurocare group AG subsidiary since 2021, it serves healthcare providers and research institutions globally.
- Company typePrivate
- Founded2002
- HeadquartersMunich, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What MAG & More does
MAG & More GmbH is a Munich-based medical device company founded in 2002 that designs, manufactures, and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The company has been a wholly-owned subsidiary of the publicly listed neurocare group AG since 2021 and operates from its headquarters on Machtlfinger Strasse 13 in Munich. Its product portfolio spans the Apollo TMS Therapy System (FDA 510(k) cleared for Major Depressive Disorder, with an additional clearance for adolescent MDD) and the PowerMAG Touch clinical system, the PowerMAG Research stimulator series (lab, EEG, ppTMS, and QPS variants) for neuroscience laboratories, the View! 3D MR-based neuronavigation system, and the Stimware integrated treatment software. Proprietary coil technology — including the aCool air-cooled coil (over 20,000 pulses at 1 Hz/75%) and the pCool coil with patented safety limit features supporting up to 100 Hz theta burst stimulation — combined with ISO 13485 manufacturing in Germany underpins the technical differentiation.
The company primarily serves two customer segments. First, clinical practices and healthcare providers — psychiatrists, psychologists, and medical clinics — that deploy TMS for treatment-resistant major depressive disorder, schizophrenia with auditory hallucinations, stroke rehabilitation, anxiety disorders, neuropathic pain, tinnitus, and migraine; the Apollo system's ~19-minute Theta Burst sessions and automatic motor threshold determination are positioned for clinical workflow efficiency. Second, research institutions and universities using PowerMAG stimulators for neuroscience studies, often integrating TMS with EEG, EMG, and MRI methodologies via the Double Coil PMD45-EEG and View! neuronavigation.
Revenue is generated predominantly through direct hardware sales of TMS systems, replacement and additional coils, and complementary accessories (treatment chairs, positioning arms, trolley, TMS field probe), supplemented by professional services (on-site installation, training led by Dr. Wolfgang Strube, and structured training courses) and managed service/support packages. Pricing is quote-based with multi-year service contracts. Distribution is a direct enterprise field-sales motion with a dedicated sales and service contact infrastructure, augmented by referral flow from the parent neurocare group's global therapy center network. Reimbursement eligibility in the US, Australia, Japan, and parts of Europe supports commercial pull-through in those geographies.
MAG & More firmographics
Firmographics- Name
- MAG & More
- Legal name
- MAG & More GmbH
- Website
- https://magandmore.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MAG & More GmbH, founded in 2002 in Munich, develops Transcranial Magnetic Stimulation (TMS) systems for treating depression and neurological conditions and for neuroscience research. A neurocare group AG subsidiary since 2021, it serves healthcare providers and research institutions globally.
- Ownership category
- akta.pro rank
MAG & More industry classification
Industry- Product category
- Transcranial Magnetic Stimulation Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
Keywords
Where MAG & More is headquartered
LocationHeadquarters
- HQ city
- Munich
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
MAG & More business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- TMS Hardware Systems: Sale of TMS therapy and research systems including Apollo TMS, PowerMAG Touch, and PowerMAG Research stimulators. Hardware sales represent core revenue with one-time purchase model for equipment.
- TMS Coils and Accessories: Replacement and additional coils (aCool, pCool, PMR, PMD70, PMD45-EEG) and accessories sold to existing customers. Repeat purchase opportunity as coils wear over time.
- Professional Services and Training: On-site installation, system training, and practical TMS courses offered. Complete Apollo TMS package includes installation, training, and full system warranty. TMS training courses conducted by Dr. Wolfgang Strube.
- Service and Support Packages: Service packages offering the right solution for individual customer requirements. Service department available for ongoing support and maintenance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise medical device pricing - quote-based |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
MAG & More product offering
Product offeringCore offering
MAG & More GmbH designs, manufactures and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The portfolio includes the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, the PowerMAG Research stimulator series for research, the View! 3D neuronavigation system for precise coil targeting, the Stimware software platform for treatment control, and a family of cooled and specialty stimulation coils. Products are manufactured in Germany under ISO 13485 with CE Class IIa certification and FDA 510(k) clearance.
Product overview
MAG & More offers a comprehensive portfolio of Transcranial Magnetic Stimulation (TMS) products for clinical therapy and neuroscience research. The clinical portfolio centers on the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, supported by the PowerMAG View! 3D Neuronavigation for precision targeting and Stimware software for treatment management. The research portfolio includes the PowerMAG Research stimulator series (in multiple variants including lab, EEG, ppTMS, and QPS models) designed for combining TMS with EEG, EMG, and MRI methodologies. Both portfolios share compatible coil accessories (aCool, pCool, PMR, PMD70, PMD45-EEG) and complementary accessories (treatment chairs, positioning equipment), all managed through the unified Stimware software platform. Products are manufactured in Germany under ISO 13485 quality management with CE Class IIa medical device certification.
Differentiator
Problem solved
Functional benefit
Brands
- Apollo TMS: Next generation TMS therapy system for depression treatment with modern user-friendly features and industry-leading biphasic pulse width.
- PowerMAG Touch
- PowerMAG Research
- View! 3D Neuronavigation
- Stimware
Products and services
- Apollo TMS Therapy System Clinical TMS system for treating Major Depressive Disorder, featuring industry-leading biphasic pulse width, intuitive touchscreen interface, automatic motor threshold determination, and treatment sessions of approximately 19 minutes. FDA 510(k) cleared and CE Class IIa certified for clinical psychiatrists, psychologists, and medical clinics.
- PowerMAG Touch TMS Therapy System
Quantifiable outcome
- Two out of three patients benefit from TMS treatment for depression
- +2 more outcomes
Companies that use MAG & More
Customer profileSegments2 records
Ideal customer profiles2 records
MAG & More technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
MAG & More partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- neurocare group AGcoreMAG & More GmbH has been part of neurocare group AG since 2021. The company maintains its operations in Munich while benefiting from the broader neurocare group's resources and market presence. neurocare group is a global provider of TMS therapy services and technology.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
MAG & More competitors and assessment
Company assessmentDirect peers
- Neuronetics: US-based, publicly listed manufacturer of NeuroStar, the leading FDA-cleared TMS system for depression. Directly competes with MAG & More's Apollo and PowerMAG Touch in clinical psychiatry practices and is the dominant US incumbent.
- Brainsway: Israel-based, publicly listed company offering Deep TMS systems (H-coil) with FDA-cleared indications including MDD and OCD. Competes head-to-head with MAG & More in clinical TMS, with broader FDA-cleared indications.
- Magstim: UK-based pioneer of TMS stimulators (founded alongside the original Magstim technology) supplying both clinical and research TMS systems globally. Overlaps directly with MAG & More's Apollo/PowerMAG clinical and research product lines.
- MagVenture: Denmark-based manufacturer of MagPro TMS systems for clinical and research use. A near-direct competitor in clinical depression TMS and neuroscience research stimulators, with similar European manufacturing heritage.
- Neurosoft: Russia-based manufacturer of clinical TMS systems (Neuro-MS/D) sold internationally. Direct competitor in clinical TMS hardware with overlapping coil and stimulator offerings.
Broad incumbents
- neurocare group AG: German, publicly listed parent of MAG & More that also operates a global network of TMS therapy centers. Comparable as a TMS ecosystem player, but broader as a services provider rather than a pure-device OEM.
- Saluda Medical: Medical device company developing advanced neurostimulation systems (Evoke) for chronic pain and other indications. Comparable as a neuromodulation device maker, though focused on implantable rather than non-invasive approaches.
Emerging players
- Ybrain: South Korea-based developer of wearable and clinical TMS systems for depression and cognitive disorders. Comparable emerging player with overlapping clinical TMS focus, particularly in Asia.
- eNeura: US-based neuromodulation company developing single-pulse TMS devices (SpringTMS) for migraine and other indications. Comparable as a non-invasive neurostimulation device maker with adjacent clinical use cases (migraine vs. depression).
- Soterix Medical: US-based developer of non-invasive brain stimulation technologies including transcranial direct current stimulation (tDCS) and high-definition systems. Comparable as a non-invasive neuromodulation hardware and research-instrument vendor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
MAG & More social profiles
Digital presenceMAG & More compliance and trust
Trust signalCompliance5 records
MAG & More financial estimates
Financial estimateRevenue estimate
Valuation estimate
MAG & More leadership team
Management profileNumber of profiles
Profiles5 records
MAG & More funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MAG & More M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MAG & More
What does MAG & More do?
MAG & More GmbH designs, manufactures and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The portfolio includes the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, the PowerMAG Research stimulator series for research, the View! 3D neuronavigation system for precise coil targeting, the Stimware software platform for treatment control, and a family of cooled and specialty stimulation coils. Products are manufactured in Germany under ISO 13485 with CE Class IIa certification and FDA 510(k) clearance.
Is MAG & More a public or private company?
MAG & More is a private company. It is classified as corporate owned and is currently operating.
When was MAG & More founded?
MAG & More was founded in 2002. It employs 1 to 10 people.
Where is MAG & More based?
MAG & More is headquartered in Munich, Germany, in the Europe region.
How does MAG & More make money?
Four revenue lines are on record. TMS Hardware Systems are the primary driver. The others are TMS Coils and Accessories, professional Services and Training and service and Support Packages.
Who are MAG & More's main competitors?
Direct peers on record are Neuronetics, Brainsway, Magstim, MagVenture and Neurosoft. Broad incumbents are neurocare group AG and Saluda Medical. Emerging players are Ybrain, eNeura and Soterix Medical.
Does MAG & More have an API?
No public API is recorded for MAG & More.
What industry is MAG & More in?
MAG & More's product category is Transcranial Magnetic Stimulation Medical Devices. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS). Its NAICS code is 334510 and its SIC code is 3845.